Therapeutic Indications

Carboprost is indicated for:

Post-partum haemorrhage

Women only, only Adults (18 - 65 years old)

Treatment of post-partum haemorrhage due to uterine atony and refractory to conventional methods of treatment with oxytocic agents and ergometrine used either alone or in combination.

Conventional therapy should usually consist of 0.5-1 mg ergometrine with up to 50 units of oxytocin infused intravenously over periods of time from 20 minutes to 12 hours. The dosage and duration of administration should reflect the seriousness of the clinical situation.

For this indication, the medical literature mentions below treatments (click for details):

Treatment 1: Intramuscular - 250-2000 ug

Contraindications

Active ingredient Carboprost is contraindicated in the following cases:

Pregnancy

No gender/age discrimination

Studies in animals have shown reproductive toxicity and any dose which produces increased uterine tone could put the embryo or foetus at risk.

Pulmonary disease

No gender/age discrimination

Hepatic disease

No gender/age discrimination

Acute pelvic inflammatory disease

No gender/age discrimination

Allergy to carboprost

No gender/age discrimination

Cardiac disease

No gender/age discrimination

Renal disease

No gender/age discrimination